(What to evaluate if you actually want sales teams to trust and use it)
Accuracy gap in legacy B2B healthcare databases.
Verified provider-to-facility affiliation links mapped.
Native compliance with PHI and HIPAA standards.
● 40% Weak Org Hierarchy
● 30% Stale Provider Data
● 30% Intent Noise
Most healthcare sales intelligence purchases fail quietly. The contract gets signed, dashboards get built, and then reps go back to spreadsheets. The failure isn't adoption. It is misdiagnosis of what "sales intelligence" needs to do in healthcare.
A real platform must reduce decision ambiguity, not just add more activity signals.
Healthcare sales aren't 1-to-1. Does the tool map IDNs, MSOs, and independent facility relationships?
🚩 Avoid tools using flat B2B "Account" models.Intelligence must verify where a doctor currently practices and holds influence.
🚩 Avoid leads without facility-specific context.Visibility into referral flows and local network dominance is the difference between a lead and a partnership.
🚩 Avoid tools that stop at the "Parent" level.Look for clinical behavior and facility expansion signals instead of web noise.
🚩 Avoid "Black Box" intent algorithms.Identify accounts in a buying cycle by analyzing budget cycles and peer adoption patterns.
🚩 Avoid "Volume-First" lead gen strategies.Intelligence must be gathered without violating PHI or privacy standards.
🚩 Avoid vendors vague on data sourcing.Insights trapped in dashboards are dead. True intelligence lives inside your CRM workflows.
🚩 Avoid "Dashboard-Only" platforms.Show me who actually decides at this health system.
Which accounts look interested but shouldn't be contacted yet?
Explain why this territory is imbalanced.
Walk me through a false positive example.
We deliver intelligence that tells reps where to focus, who matters, and when to wait.
Account intelligence that reflects reality.
Identity resolution focused on authority.
Signals that indicate permission to buy.
Insights that respect regulatory boundaries.